1. Home
  2. GDTC vs PBBK Comparison

GDTC vs PBBK Comparison

Compare GDTC & PBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • PBBK
  • Stock Information
  • Founded
  • GDTC 2018
  • PBBK 1919
  • Country
  • GDTC Singapore
  • PBBK United States
  • Employees
  • GDTC N/A
  • PBBK N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • PBBK Banks
  • Sector
  • GDTC Health Care
  • PBBK Finance
  • Exchange
  • GDTC Nasdaq
  • PBBK Nasdaq
  • Market Cap
  • GDTC 33.4M
  • PBBK 35.9M
  • IPO Year
  • GDTC 2023
  • PBBK N/A
  • Fundamental
  • Price
  • GDTC $2.37
  • PBBK $15.49
  • Analyst Decision
  • GDTC Buy
  • PBBK
  • Analyst Count
  • GDTC 1
  • PBBK 0
  • Target Price
  • GDTC $5.00
  • PBBK N/A
  • AVG Volume (30 Days)
  • GDTC 24.9K
  • PBBK 1.6K
  • Earning Date
  • GDTC 01-01-0001
  • PBBK 11-13-2024
  • Dividend Yield
  • GDTC N/A
  • PBBK N/A
  • EPS Growth
  • GDTC N/A
  • PBBK N/A
  • EPS
  • GDTC N/A
  • PBBK 0.64
  • Revenue
  • GDTC $330,254.00
  • PBBK $11,875,000.00
  • Revenue This Year
  • GDTC $14.71
  • PBBK N/A
  • Revenue Next Year
  • GDTC N/A
  • PBBK N/A
  • P/E Ratio
  • GDTC N/A
  • PBBK $24.30
  • Revenue Growth
  • GDTC N/A
  • PBBK N/A
  • 52 Week Low
  • GDTC $1.20
  • PBBK $11.90
  • 52 Week High
  • GDTC $5.50
  • PBBK $17.50
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 45.29
  • PBBK 68.19
  • Support Level
  • GDTC $2.43
  • PBBK $15.09
  • Resistance Level
  • GDTC $3.00
  • PBBK $14.58
  • Average True Range (ATR)
  • GDTC 0.41
  • PBBK 0.13
  • MACD
  • GDTC -0.03
  • PBBK 0.12
  • Stochastic Oscillator
  • GDTC 21.60
  • PBBK 100.00

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About PBBK PB Bankshares Inc.

PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.

Share on Social Networks: